Introduction
Managing inflammatory bowel disease can involve ongoing treatment, regular medical care, and significant medication expenses. Omvoh is a specialty biologic used for adults with moderately to severely active ulcerative colitis or Crohn’s disease, and the cost of treatment can add another concern for patients and families.
Omvoh contains mirikizumab-mrkz, a humanized monoclonal antibody that selectively targets the p19 subunit of interleukin-23. By blocking IL-23 signaling, Omvoh can help reduce immune activity involved in intestinal inflammation.
Treatment with Omvoh includes an initial intravenous induction period followed by subcutaneous maintenance injections. Because the medication involves both infusion and injection-based treatment, overall treatment costs can vary based on the patient’s condition, treatment setting, insurance coverage, and other factors.
Prescription Hope provides medication assistance support for eligible patients seeking more affordable access to prescription medications. Understanding available patient assistance options can be an important part of managing the financial side of treatment with Omvoh.
What Is the Omvoh Patient Assistance Program?
Understanding Omvoh Prescription Assistance
What are patient assistance programs?
Pharmaceutical manufacturers understand that some of their brand-name medications may be too expensive for average Americans to pay out-of-pocket. When patients have inadequate insurance coverage or financial assistance, the burden of monthly medication costs can be too much.
Patients needing patient assistance programs for inflammatory bowel disease need look no further than the Omvoh patient assistance program.
The program offers Omvoh at an affordable rate to qualified patients who meet certain requirements that fall under categories such as income, insurance, valid prescription, and residency.
However, many patient assistance programs have been known for their difficult application process.
There is a solution.
How Expert Advocates Help Make Omvoh More Affordable
Personalized Medication Assistance
Prescription Hope offers Omvoh cost support services as well as support services for hundreds of other brand-name medications.
Our team of patient advocates works on behalf of patients throughout the application process, completing forms, collecting documents and signatures, coordinating with healthcare providers and manufacturers, and much more.
All so patients can focus on the more important things in life – quality of life and loved ones.
Ongoing Patient Support
Patients dealing with conditions such as inflammatory bowel disease, among others, often need ongoing prescription assistance.
Prescription Hope not only provides help accessing Omvoh, but continues to handle the administrative tasks associated with a medication’s patient assistance program.
Our team manages refill scheduling, document updates, issue resolution, yearly renewals, and more.
Omvoh Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Treatment Costs
Due to rising specialty drug costs, many patients cannot afford their medication out-of-pocket.
Prescription Hope offers all of their services for a simple $70.00 per month, per medication.
This means no add-on charges, hidden fees, variable pricing, or even medication costs.
Plus, if we cannot help a patient save on their medication, then they pay nothing.
Omvoh Patient Assistance Eligibility
General Eligibility Requirements
Each patient assistance program maintains its own unique criteria for approval.
Every program uses several general categories to determine its qualification standards. Some of those general categories include:
Income: All programs require an income that falls within a specific range. Each program differs in the required range.
Insurance: Each program maintains a selected insurance coverage status. Some programs require a qualified patient to have no coverage, while others may allow some form of coverage.
Prescription: Qualified patients must have a valid and current prescription for the medication they wish to apply for.
Residency: All qualified patients must be legal U.S. residents.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Ready to get started with your Omvoh patient assistance enrollment through Prescription Hope?
Complete these 6 simple steps:
- Submit Information: Complete our online form in only a few minutes.
- Advocate Contact: After we receive your completed form, we’ll reach out within 1-2 business days.
- Document Collection: Once we’ve prequalified you, our team collects all necessary documents.
- Provider Coordination: We also connect with your healthcare provider to gather needed signatures.
- Program Submission: Once everything is in order, our team submits your application packet and follows up with the manufacturer.
- Medication Delivery: After approval, medication ships directly from the manufacturer to your door or doctor’s office. Qualified patients can typically expect their medication to arrive within 2 weeks.
Please note: Prescription Hope is not a pharmacy or manufacturer and does not at any time handle medications.
Understanding Omvoh
How Omvoh Works
Omvoh contains mirikizumab-mrkz, a humanized IgG4 monoclonal antibody that selectively targets the p19 subunit of interleukin-23, also known as IL-23.
IL-23 is involved in immune-system signaling and intestinal inflammation. By binding to the p19 subunit of IL-23, mirikizumab prevents IL-23 from interacting with its receptor. This reduces signaling involved in the production and activity of certain pro-inflammatory cytokines and chemokines.
In simpler terms, Omvoh blocks a specific immune pathway that contributes to inflammation in inflammatory bowel disease. By reducing this pathway’s activity, the medication can help decrease inflammation in the intestinal tract.
Omvoh is administered intravenously during the initial induction phase and then by subcutaneous injection during maintenance treatment. The specific dosing schedule depends on whether Omvoh is being used for ulcerative colitis or Crohn’s disease.
What Conditions Does Omvoh Treat?
Omvoh is FDA-approved for adults with moderately to severely active ulcerative colitis and adults with moderately to severely active Crohn’s disease.
For ulcerative colitis, this medication was initially approved by the FDA in October 2023. It is used for adults whose disease is moderately to severely active.
The FDA expanded its approved uses in January 2025 to include adults with moderately to severely active Crohn’s disease.
Omvoh is not currently FDA-approved for pediatric patients, and its safety and effectiveness have not been established in children.
For ulcerative colitis, the initial induction regimen consists of 300 mg administered by intravenous infusion at Weeks 0, 4, and 8. Maintenance treatment begins at Week 12 with 200 mg administered subcutaneously every four weeks.
For Crohn’s disease, the induction regimen consists of 900 mg administered by intravenous infusion at Weeks 0, 4, and 8. Maintenance treatment begins at Week 12 with 300 mg administered subcutaneously every four weeks.
Benefits of Treatment
For appropriately selected adults with moderately to severely active ulcerative colitis or Crohn’s disease, Omvoh provides a targeted biologic treatment option designed to reduce inflammation associated with inflammatory bowel disease.
Clinical studies demonstrated improvements in clinical remission and endoscopic measures of disease activity compared with placebo in both ulcerative colitis and Crohn’s disease.
Treatment with Omvoh may help reduce intestinal inflammation and improve symptoms associated with active inflammatory bowel disease. In Crohn’s disease, treatment may also help reduce abdominal pain and stool frequency. Some patients may achieve corticosteroid-free clinical remission.
It also provides a maintenance treatment option that can be administered by subcutaneous injection every four weeks following the initial intravenous induction period.
Individual responses to treatment vary. Treatment outcomes depend on factors such as the patient’s condition, disease activity, previous treatments, and overall health.
Important Safety Information and Side Effects
Omvoh does not carry an FDA Boxed Warning. However, the medication has important warnings and precautions involving serious hypersensitivity reactions, infections, tuberculosis, liver injury, and immunizations.
Precautions and warnings are included for side effects and adverse reactions such as:
- Anaphylaxis
- Infusion-related reactions
- Infections
- Tuberculosis
- Hepatoxicity
Immunizations
Patients should complete age-appropriate vaccinations before beginning Omvoh when possible.
Live vaccines should be avoided during treatment with this medication. Patients should tell healthcare providers that they are receiving it before receiving vaccinations.
Pregnancy
Available human pregnancy data are insufficient to determine whether Omvoh increases the risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes.
Because mirikizumab is a monoclonal antibody, it may cross the placenta, particularly later in pregnancy. The FDA labeling notes that mirikizumab may cause immunosuppression in an infant exposed in utero.
Infants exposed to Omvoh in utero should be monitored for serious infections during the first two months of life.
Breastfeeding
There are no available data regarding the presence of mirikizumab-mrkz in human milk, its effects on a breastfed infant, or its effects on milk production.
Patients and healthcare providers should consider the developmental and health benefits of breastfeeding together with the mother’s clinical need for Omvoh and any potential adverse effects on the breastfed infant.
Drug Interactions
Omvoh does not have the broad range of conventional drug interactions associated with many small-molecule medications. However, changes in inflammatory cytokine levels can affect the formation of certain CYP450 enzymes.
By reducing inflammatory signaling, mirikizumab may alter exposure to some CYP450 substrates. When this medication is started or discontinued in a patient taking a CYP450 substrate with a narrow therapeutic index, healthcare providers may monitor drug concentrations or other appropriate therapeutic measures and adjust the substrate dosage when necessary.
Common Side Effects
The most common adverse reactions can vary depending on the condition being treated and whether the patient is receiving induction or maintenance therapy.
During intravenous induction for ulcerative colitis:
- Upper respiratory tract infections
- Arthralgia, or joint pain
During maintenance treatment for ulcerative colitis:
- Upper respiratory tract infections
- Injection-site reactions
- Arthralgia
- Rash
- Headache
- Herpes viral infections
For Crohn’s disease:
- Upper respiratory tract infections
- Injection-site reactions
- Headache
- Arthralgia
- Elevated liver tests
Patients should discuss their individual health history, current medications, and potential risks with their healthcare provider before and during treatment with Omvoh.
Access to Multiple Medications
Support Beyond Omvoh
The CDC reports that from 2017 to March 2020, 24.7% of people used three or more prescription drugs in the past 30 days.
This means many Americans may require more than one patient assistance program.
Prescription Hope offers qualified patients access to hundreds of affordable brand-name medications through patient assistance programs.
Our service rate of $70.00 per month, per medication, never changes, no matter the medication accessed or length of service.
Why Choose Prescription Hope for Omvoh Assistance
Patient-Focused Medication Support
For 20 years, we’ve provided compassionate patient-focused medication assistance services. Our team expertly navigates the patient assistance program application process, as well as the administrative process long after approval.
Simplified Access to Specialty Therapies
Our service rate for specialty medication assistance is a simple and consistent $70.00 per month, per medication.
Ongoing Prescription Assistance
Not only do we provide support and advocacy throughout the application process, but we manage things like refill scheduling, document updates, issue resolution, yearly renewals, and more.
If you need to access affordable medication, then be sure to enroll with Prescription Hope today!